Celgene Ended Theranos Deal Early Over Bad Data, Jury Told
A former Celgene senior scientist testified in ex-Theranos CEO Elizabeth Holmes' criminal fraud trial Wednesday that the pharmaceutical company cut short its deal with Theranos to help it in clinical trial...To view the full article, register now.
Already a subscriber? Click here to view full article